BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $121,068 | +4.1% | 3,276 | +28.3% | 0.01% | 0.0% |
Q2 2023 | $116,304 | +31.7% | 2,553 | +34.4% | 0.01% | +20.0% |
Q1 2023 | $88,293 | -81.7% | 1,899 | -80.0% | 0.01% | -84.8% |
Q4 2022 | $483,232 | -4.3% | 9,481 | +2.1% | 0.03% | -13.2% |
Q3 2022 | $505,000 | -1.8% | 9,287 | +16.1% | 0.04% | -7.3% |
Q2 2022 | $514,000 | -9.0% | 7,999 | +4.7% | 0.04% | -6.8% |
Q1 2022 | $565,000 | +73.3% | 7,639 | +88.7% | 0.04% | +37.5% |
Q3 2021 | $326,000 | +887.9% | 4,049 | +880.4% | 0.03% | +966.7% |
Q2 2021 | $33,000 | 0.0% | 413 | +4.6% | 0.00% | -25.0% |
Q1 2021 | $33,000 | +3.1% | 395 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $32,000 | -8.6% | 395 | -9.2% | 0.00% | -20.0% |
Q3 2020 | $35,000 | -62.8% | 435 | -60.0% | 0.01% | -66.7% |
Q2 2020 | $94,000 | +184.8% | 1,087 | +169.1% | 0.02% | +150.0% |
Q1 2020 | $33,000 | -5.7% | 404 | -3.6% | 0.01% | +20.0% |
Q4 2019 | $35,000 | -7.9% | 419 | -2.8% | 0.01% | -16.7% |
Q3 2019 | $38,000 | 0.0% | 431 | -8.1% | 0.01% | -14.3% |
Q2 2019 | $38,000 | -13.6% | 469 | -13.0% | 0.01% | -36.4% |
Q1 2019 | $44,000 | +25.7% | 539 | +0.2% | 0.01% | +22.2% |
Q4 2018 | $35,000 | -35.2% | 538 | -23.7% | 0.01% | -25.0% |
Q3 2018 | $54,000 | +17.4% | 705 | +14.1% | 0.01% | 0.0% |
Q2 2018 | $46,000 | +31.4% | 618 | +16.2% | 0.01% | +20.0% |
Q1 2018 | $35,000 | +75.0% | 532 | +73.9% | 0.01% | +100.0% |
Q4 2017 | $20,000 | +66.7% | 306 | +56.9% | 0.01% | 0.0% |
Q3 2017 | $12,000 | 0.0% | 195 | +0.5% | 0.01% | -16.7% |
Q2 2017 | $12,000 | +20.0% | 194 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $10,000 | +11.1% | 194 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $9,000 | – | 194 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |